Best- and Worst-Performing Stocks of Q2 2024
Nvidia and Alnylam Pharmaceuticals rank among the best stocks for the quarter, while the worst include Builders Firstsource and Walgreens Boots Alliance.
The Morningstar US Large-Mid Cap Index rose 4% in the second quarter, thanks to continued gains in the technology sector. The index tracks the performance of the top 90% of the US investable universe by market cap, and each quarter we screen it to find the best- and worst-performing companies. Data in this article is sourced from Morningstar Direct.
Best-Performing Stocks of the Second Quarter 2024
Worst-Performing Stocks of the Second Quarter 2024
- Walgreens Boots Alliance WBA
- Five Below FIVE
- Unity Software U
- Exact Sciences EXAS
- Builders Firstsource BLDR
Metrics for the Best-Performing Stocks
Alnylam Pharmaceuticals
- Sector: Healthcare
- Industry: Biotechnology
- Economic Moat: Narrow
Alnylam surged 62.6% in the second quarter, bringing it up 31.3% over the past year. The company’s stock has a Morningstar Rating of 3 stars and is trading at a 9% premium to its fair value estimate of $223.
Snap
- Sector: Communication Services
- Industry: Internet Content & Information
- Economic Moat: None
Snap rallied 44.7%, bringing it up 62.8% over the past year. The company’s stock has a Morningstar Rating of 3 stars and is trading at a 19% premium to its fair value estimate of $14.
United Therapeutics
- Sector: Healthcare
- Industry: Biotechnology
- Economic Moat: None
United Therapeutics surged 38.7%, leaving it up 51.9% for the year. The company’s stock has a Morningstar Rating of 2 stars and is trading at a 44% premium to its fair value estimate of $221.
Nvidia
- Sector: Technology
- Industry: Semiconductors
- Economic Moat: Wide
Nvidia climbed 36.7%, lifting shares 226.7% over the past year. Shares are 37% below their last high on June 10, 2024. The company’s stock has a Morningstar Rating of 3 stars and is trading at an 18% premium to its fair value estimate of $105.
First Solar
- Sector: Technology
- Industry: Solar
- Economic Moat: None
First Solar advanced 33.6%, bringing the stock up 11.1% over the past year. Shares are 26.5% below their last high on June 12, 2024. The company’s stock has a Morningstar Rating of 2 stars and is trading at a 22% premium to its fair value estimate of $185.
Metrics for the Worst-Performing Stocks
Walgreens Boots Alliance
- Sector: Healthcare
- Industry: Pharmaceutical Retailers
- Economic Moat: None
Walgreens plunged 43.5% in the quarter, leaving the stock down 57.4% for the year. Shares are 61.4% below their last high on July 27, 2023. The company’s stock has a Morningstar Rating of 4 stars and is trading at a 47% discount to its fair value estimate of $23.
Five Below
- Sector: Consumer Cyclical
- Industry: Specialty Retail
- Economic Moat: Not Rated
Five Below fell 39.9%, down 36.8% from one year ago. Shares are 49.6% below their last high on Jan. 2, 2024. The company’s stock has a quantitative Morningstar Rating of 3 stars.
Unity Software
- Sector: Technology
- Industry: Software - Application
- Economic Moat: Not Rated
Unity Software fell 39.1%, down 45.3% from one year ago. Shares are 67.5% below their last high on July 19, 2023. The company’s stock has a quantitative Morningstar Rating of 3 stars.
Exact Sciences
- Sector: Healthcare
- Industry: Diagnostics & Research
- Economic Moat: None
Exact Sciences plunged 38.8%, leaving it down 48.2% for the year. Shares are 58.1% below their last high on July 19, 2023. The company’s stock has a Morningstar Rating of 4 stars and is trading at a 46% discount to its fair value estimate of $78.
Builders Firstsource
- Sector: Industrials
- Industry: Building Products & Equipment
- Economic Moat: Not Rated
Builders Firstsource tumbled 33.6% but was still up 19.4% from one year ago. Shares are 35.5% below their last high on March 21, 2024. The company’s stock has a quantitative Morningstar Rating of 3 stars.
Companies that are not formally covered by a Morningstar analyst are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative star rating.
This article was generated with the help of automation and reviewed by Morningstar editors. Learn more about Morningstar’s use of automation.
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.